✦ LIBER ✦

In vivo visualization of rat anaplastic carcinoma with 131I—antiferritin antibodies

✍ Scribed by Lukač, J.; Kordić, D.; Matić-Piantanida, D.; Spaventi, Š.

Book ID: 122980847
Publisher: Elsevier Science
Year: 1987
Weight: 568 KB
Volume: 14
Category: Article
ISSN: 0883-2897
DOI: 10.1016/0883-2897(87)90108-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radioimmunotherapy of human hepatocellul

Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody

✍ Saiful Alam, AFM 📂 Article 📅 1991 🏛 Nature Publishing Group 🌐 English ⚖ 933 KB

Radioimmunoscintigraphy of human pancrea

Radioimmunoscintigraphy of human pancreatic carcinoma xenografts in nude mice with131I-labeled monoclonal antibody

✍ Takatoshi Tsuda; H. Koshiba; T. Usui; M. Kubota; Kokichi Kikuchi; Kazuo Morita 📂 Article 📅 1990 🏛 Springer Japan 🌐 English ⚖ 638 KB

Specific imaging of hormone-dependent ma

Specific imaging of hormone-dependent mammary carcinoma in nude mice with [131I]-anti-estriol 3-sulfate antibody

✍ Noriko Shimura; Shuji Kojima; Akiko Kubodera; Takashi Tsuruo 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 658 KB

Localization of mammary tumors in vivo w

Localization of mammary tumors in vivo with 131i-labeled fab fragments of antibodies against mouse mammary epithelial (mme) antigens

✍ Tyr Wilbanks; Jerry A. Peterson; Shelby Miller; Leon Kaufman; Douglas Ortendahl; 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 826 KB

Biological distribution of 131I-labeled

Biological distribution of 131I-labeled anti-nucleus antigen monoclonal antibody chTNT in patients with pulmonary metastases from differentiated thyroid carcinoma

✍ MA, Q; GAO, S; ZHAO, J; WEN, Q; BAI, L; ZHANG, H; ZHAO, G 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Phase I/II trial of 131I-MN-14 F(ab)2 an

Phase I/II trial of 131I-MN-14 F(ab)2 anti–carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma

✍ Malik E. Juweid; George Hajjar; Lawrence C. Swayne; Robert M. Sharkey; Samer Sul 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 1 views

## BACKGROUND. Monoclonal antibodies (MAbs) against carcinoembryonic antigen (CEA) have been recognized as targeting agents for medullary thyroid carcinoma (MTC). This Phase I/II study was initiated to determine the safety, maximum tolerated dose (MTD), and therapeutic potential of 131 I-MN-14 F(ab